Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 627

1.

Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease.

Hawranek M, Zembala MO, Gasior M, Hrapkowicz T, Pyka Ł, Cieśla D, Zembala M.

Oncotarget. 2018 Apr 20;9(30):21201-21210. doi: 10.18632/oncotarget.25006. eCollection 2018 Apr 20.

2.

Mechanical circulatory support is effective to treat pulmonary hypertension in heart transplant candidates disqualified due to unacceptable pulmonary vascular resistance.

Zakliczyński M, Pacholewicz J, Copik I, Maruszewski M, Hrapkowicz T, Przybylski R, Zembala M.

Kardiochir Torakochirurgia Pol. 2018 Mar;15(1):23-26. doi: 10.5114/kitp.2018.74671. Epub 2018 Mar 28.

3.

Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease: 5-Year Clinical Outcomes of the Prospective Randomized Pilot Study.

Tajstra M, Hrapkowicz T, Hawranek M, Filipiak K, Gierlotka M, Zembala M, Gąsior M, Zembala MO; POL-MIDES Study Investigators.

JACC Cardiovasc Interv. 2018 May 14;11(9):847-852. doi: 10.1016/j.jcin.2018.01.271. Epub 2018 Apr 18.

PMID:
29680218
4.

Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial).

Dudek D, Ebner A, Sobczyński R, Trębacz J, Vesga B, Granada J, Zembala M, Witkowski A, Van Mieghem NM, Sood P, Ochała A, Dziewierz A, Żmudka K.

Am J Cardiol. 2018 Mar 13. pii: S0002-9149(18)30282-0. doi: 10.1016/j.amjcard.2018.02.046. [Epub ahead of print]

PMID:
29655880
5.

The Columbus of cardiovascular surgery. A tribute to Francis Fontan (1929-2018).

Mazurak M, Kusa J, Orantek S, Zembala M.

Kardiol Pol. 2018;76(4):814-815. doi: 10.5603/KP.2018.0088. No abstract available.

6.

Prognostic value of selected risk scales in patients with end-stage heart failure.

Szczurek W, Szyguła-Jurkiewicz B, Zakliczyński MW, Król B, Gąsior M, Zembala M.

Kardiol Pol. 2018 Apr 10. doi: 10.5603/KP.a2018.0090. [Epub ahead of print]

7.

Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial.

Benedetto U, Altman DG, Flather M, Gerry S, Gray A, Lees B, Taggart DP; Arterial Revascularization Trial Investigators.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2346-2355.e6. doi: 10.1016/j.jtcvs.2018.02.012. Epub 2018 Feb 13.

PMID:
29559261
8.

Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial).

Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Angelini GD, Flather M, Taggart DP; ART (Arterial Revascularization Trial) Investigators.

J Am Heart Assoc. 2018 Mar 3;7(5). pii: e007570. doi: 10.1161/JAHA.117.007570.

9.

Prognostic utility of the N terminal prohormone of brain natriuretic peptide and the modified Model for End Stage Liver Disease in patients with end stage heart failure.

Szczurek W, Szyguła-Jurkiewicz B, Zakliczyński M, Król B, Gąsior M, Zembala M.

Pol Arch Intern Med. 2018 Apr 30;128(4):235-243. doi: 10.20452/pamw.4210. Epub 2018 Feb 21.

10.

The first successful bridging with an Impella CP® to minimally invasive HeartMate 3 LVAD implantation in Poland.

Antończyk K, Antończyk R, Zembala M, Zakliczyński M, Zembala MO.

Kardiol Pol. 2018;76(1):209. doi: 10.5603/KP.2018.0014. No abstract available.

11.

Effect of hybrid treatment on rehabilitation and clinical condition of patients with multivessel coronary artery disease.

Foik J, Brzęk A, Gierlotka MJ, Zembala MO, Gąsior M, Zembala M.

Pol Arch Intern Med. 2018 Feb 28;128(2):77-88. doi: 10.20452/pamw.4179. Epub 2018 Jan 2.

12.

Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation.

Ochman M, Maruszewski M, Wojarski J, Żegleń S, Karolak W, Stanjek-Cichoracka A, Przybyłowski P, Zembala M, Kukla M.

Ann Transplant. 2017 Dec 26;22:761-768.

13.

Primary pericardial mesothelioma in a 48-year-old patient.

Kowalczuk-Wieteska A, Filipiak K, Miszalski-Jamka K, Nozynski J, Zembala M.

Pol Arch Intern Med. 2017 Nov 30;127(11):792-793. doi: 10.20452/pamw.4155. Epub 2017 Nov 24. No abstract available.

14.

First Polish analysis of the treatment of advanced heart failure in children with the use of BerlinHeart EXCOR mechanical circulatory support.

Pawlak S, Przybylski R, Skalski J, Śliwka J, Kansy A, Grzybowski A, Wierzyk A, Białkowski J, Maruszewski B, Zembala M.

Kardiol Pol. 2018;76(1):83-90. doi: 10.5603/KP.a2017.0201. Epub 2017 Nov 23.

15.

State-of-the-art of transcatheter treatment of aortic valve stenosis and the overview of the InFlow project aiming at developing the first Polish TAVI system.

Kachel M, Milewski K, Buszman P, Michalak M, Domaradzki W, Gerber W, Śliwka J, Nożyński J, Sobota M, Hirnle P, Białek-Brodocz M, Zembala M, Pawlak M, Płowiecki E, Kasperczyk J, Mężyk A, Bochenek A, Buszman P.

Cardiol J. 2017;24(6):685-694. doi: 10.5603/CJ.a2017.0134. Epub 2017 Nov 23.

16.

Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry.

Möllmann H, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Walther T, Zembala MO, Toggweiler S, Kim WK.

EuroIntervention. 2018 Feb 2;13(15):e1764-e1770. doi: 10.4244/EIJ-D-17-00628.

17.

Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society….

Parma R, Zembala MO, Dąbrowski M, Jagielak D, Witkowski A, Suwalski P, Dudek D, Olszówka P, Wojakowski W, Przybylski R, Gil R, Kuśmierczyk M, Lesiak M, Sadowski J, Dobrzycki S, Ochała A, Hoffman P, Kapelak B, Kaźmierczak J, Jasiński M, Stępińska J, Szymański P, Hryniewiecki T, Kochman J, Grygier M, Zembala M, Legutko J, Różański J.

Kardiol Pol. 2017;75(9):937-964. doi: 10.5603/KP.2017.0175.

PMID:
28895996
18.

Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.

Huczek Z, Zbroński K, Grodecki K, Scisło P, Rymuza B, Kochman J, Dąbrowski M, Witkowski A, Wojakowski W, Parma R, Ochała A, Grygier M, Olasińska-Wiśniewska A, Araszkiewicz A, Jagielak D, Ciećwierz D, Puchta D, Paczwa K, Filipiak KJ, Wilimski R, Zembala M, Opolski G.

Catheter Cardiovasc Interv. 2018 Jan 1;91(1):115-123. doi: 10.1002/ccd.27251. Epub 2017 Aug 26.

PMID:
28843025
19.

Successful use of Impella CP® in cardiogenic shock after cardiac arrest: a first in Poland.

Nadziakiewicz P, Zembala M, Słonka G, Balak W.

Kardiol Pol. 2017;75(8):812. doi: 10.5603/KP.2017.0155. No abstract available.

20.

The Effects of the Structure and Composition of the Hydrophobic Parts of Phosphatidylcholine-Containing Systems on Phosphatidylcholine Oxidation by Ozone.

Rudolphi-Skórska E, Filek M, Zembala M.

J Membr Biol. 2017 Oct;250(5):493-505. doi: 10.1007/s00232-017-9976-8. Epub 2017 Aug 10.

Supplemental Content

Loading ...
Support Center